Aurora Cannabis Inc. (ACB)

7,42 +1,14 (+18,15%) Alla chiusura: 04:00PM EDT

Aurora Cannabis Inc.

2207 90B Street SW
Edmonton, AB T6X 1V8
Canada

https://www.auroramj.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 1.130

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Miguel Martin	CEO & Director	1,47M	N/D	1973
Mr. Alex Miller	Executive Vice President of Operations & Supply Chain	362,15k	N/D	N/D
Ms. Lori Schick	Executive Vice President of Human Resources	343,51k	N/D	N/D
Mr. Andre Jerome	Executive Vice President of Global Business Development	333,23k	N/D	N/D
Ms. Simona King	Chief Financial Officer	N/D	N/D	1973
Ananth Krishnan	Vice President of Capital Markets & Investor Relations	N/D	N/D	N/D
Ms. Nathalie Clark	Executive VP, General Counsel & Corporate Secretary	N/D	N/D	N/D
Michelle Lefler	Vice President of Communications & Public Relations	N/D	N/D	N/D
Dr. Jonathan Page Ph.D.	Senior Science Advisor	N/D	N/D	1969
Mr. Rick Savone	Senior Vice President of Global Government Relations	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Governance aziendale

L'ISS Governance QualityScore di Aurora Cannabis Inc. al 1 aprile 2024 è 7. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 5; diritti degli azionisti: 7; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.